Edward M Atkinson, Iii

Title: The Innovative Contributions of Edward M Atkinson, III

Introduction

Edward M Atkinson, III is a notable inventor based in Seattle, WA, with a remarkable portfolio of eight patents. His work primarily focuses on advancements in biotechnology, particularly in the fields of gene delivery and telomerase research.

Latest Patents

One of his latest patents involves producing telomerase activators and inhibitors by screening with purified telomerase. This invention provides purified telomerase and methods of purifying it through several sequential steps. These steps include the use of matrices that bind molecules bearing negative and positive charges, intermediate-selectivity matrices, and methods that separate molecules based on size, shape, or buoyant density. Another significant patent details methods for generating high titer helper-free preparations of released recombinant AAV vectors. This invention offers methods and compositions for producing high titer, substantially purified preparations of recombinant adeno-associated virus (AAV) that can be utilized as vectors for gene delivery. The AAV vector preparations produced are generally replication incompetent but capable of mediating the delivery of therapeutic genes to various tissues and cells.

Career Highlights

Throughout his career, Edward has worked with prominent companies such as Geron Corporation and Targeted Genetics Corporation. His contributions to these organizations have significantly advanced the field of biotechnology and gene therapy.

Collaborations

Edward has collaborated with notable professionals in his field, including Scott L Weinrich and Serge P Lichtsteiner. These collaborations have further enriched his research and innovations.

Conclusion

Edward M Atkinson, III's contributions to biotechnology through his patents and collaborations highlight his significant impact on the field. His innovative work continues to pave the way for advancements in gene therapy and related technologies.